{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T22:14:31Z","timestamp":1769552071558,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Gastroenterol"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1007\/s12664-022-01335-3","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T12:02:40Z","timestamp":1684238560000},"page":"192-198","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diagnostic performance of non-invasive liver fibrosis risk scores in biopsy-proven non-alcoholic fatty liver disease patients in India"],"prefix":"10.1007","volume":"42","author":[{"given":"Manya","family":"Prasad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunanda","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikky","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umesh","family":"Kapil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,5,16]]},"reference":[{"key":"1335_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.jhep.2018.10.033","volume":"70","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol. 2019;70:531\u201344.","journal-title":"J Hepatol"},{"key":"1335_CR2","doi-asserted-by":"crossref","unstructured":"Sarin SK, Kumar M, Eslam, et al. Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2020;5:167\u2013228.","DOI":"10.1016\/S2468-1253(19)30342-5"},{"key":"1335_CR3","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1136\/gutjnl-2020-322572","volume":"70","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Petracca G, Beatrice G, Tilg H, Byrne CD, Targher G. Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut. 2021;70:962\u20139.","journal-title":"Gut"},{"key":"1335_CR4","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s12664-010-0069-1","volume":"29","author":"A Duseja","year":"2010","unstructured":"Duseja A. Nonalcoholic fatty liver disease in India - a lot done, yet more required! Indian J Gastroenterol. 2010;29:217\u201325.","journal-title":"Indian J Gastroenterol"},{"key":"1335_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","volume":"6","author":"G Targher","year":"2021","unstructured":"Targher G, Tilg H, Byrne CD. Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach. Lancet Gastroenterol Hepatol. 2021;6:578\u201388.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1335_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jhep.2019.03.033","volume":"71","author":"A Srivastava","year":"2019","unstructured":"Srivastava A, Gailer R, Tanwar S, et al. Prospective evaluation of a primary care referral pathway for patients with non-alcoholic fatty liver disease. J Hepatol. 2019;71:371\u20138.","journal-title":"J Hepatol"},{"key":"1335_CR7","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology. 2005;41:1313\u201321.","journal-title":"Hepatology"},{"key":"1335_CR8","doi-asserted-by":"crossref","unstructured":"Sterling RK, Lissen E, Clumeck N, et al. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection.\u00a0Hepatology. 2006;43:1317\u201325.","DOI":"10.1002\/hep.21178"},{"key":"1335_CR9","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1002\/hep.21496","volume":"45","author":"P Angulo","year":"2007","unstructured":"Angulo P, Hui JM, Marchesini G, et al. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Hepatology. 2007;45:846\u201354.","journal-title":"Hepatology"},{"key":"1335_CR10","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S2468-1253(18)30077-3","volume":"3","author":"EA Tsochatzis","year":"2018","unstructured":"Tsochatzis EA, Newsome PN. Non-alcoholic fatty liver disease and the interface between primary and secondary care. Lancet Gastroenterol Hepatol. 2018;3:509\u201317.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"1335_CR11","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1111\/liv.14825","volume":"41","author":"JM Schattenberg","year":"2021","unstructured":"Schattenberg JM, Lazarus JV, Newsome PN, et al. Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis in five European countries in 2018: a cost-of-illness analysis. Liver Int. 2021;41:1227\u201342.","journal-title":"Liver Int"},{"key":"1335_CR12","doi-asserted-by":"crossref","unstructured":"Das MK, Bhatia V, Sibal A, et al. Prevalence of nonalcoholic fatty liver disease in normal-weight and overweight preadolescent children in Haryana, India. Indian Pediatr. 2017;54:1012\u20136.","DOI":"10.1007\/s13312-017-1202-3"},{"key":"1335_CR13","doi-asserted-by":"publisher","first-page":"291","DOI":"10.4103\/ijmr.IJMR_1966_16","volume":"148","author":"V Jain","year":"2018","unstructured":"Jain V, Jana M, Upadhyay B, et al. Prevalence, clinical & biochemical correlates of non-alcoholic fatty liver disease in overweight adolescents. Indian J Med Res. 2018;148:291\u2013301.","journal-title":"Indian J Med Res"},{"key":"1335_CR14","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1111\/liv.14907","volume":"41","author":"A Mantovani","year":"2021","unstructured":"Mantovani A, Valenti L. A call to action for fatty liver disease. Liver Int. 2021;41:1182\u20135.","journal-title":"Liver Int"},{"key":"1335_CR15","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/j.aohep.2020.08.066","volume":"19","author":"R Zambrano-Huailla","year":"2020","unstructured":"Zambrano-Huailla R, Guedes L, Stefano JT, et al. Diagnostic performance of three non-invasive fibrosis scores (Hepamet, FIB-4, NAFLD fibrosis score) in NAFLD patients from a mixed Latin American population. Ann Hepatol. 2020;19:622\u20136.","journal-title":"Ann Hepatol"},{"key":"1335_CR16","doi-asserted-by":"crossref","unstructured":"Shah AG, Lydecker A, Murray K, et al. Comparison of noninvasive markers of fibrosis in patients with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2009;7:1104-12.","DOI":"10.1016\/j.cgh.2009.05.033"},{"key":"1335_CR17","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1111\/liv.14669","volume":"41","author":"J Lee","year":"2021","unstructured":"Lee J, Vali Y, Boursier J, et al. Prognostic accuracy of FIB-4, NAFLD fibrosis score and APRI for NAFLD-related events: a systematic review. Liver Int. 2021;41:261\u201370.","journal-title":"Liver Int"},{"key":"1335_CR18","doi-asserted-by":"crossref","unstructured":"Mehta M, Duseja A, Dass A, Dhiman RK, Taneja S. 21. Non-alcoholic faty liver disease (NAFLD) fibrosis score (NFS) in predicting hepatic fibrosis in patients with NAFLD. J Clin Exp Hepatol 2018;8 Suppl 1: S44 -5.","DOI":"10.1016\/j.jceh.2018.06.351"},{"key":"1335_CR19","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jceh.2016.08.006","volume":"6","author":"MM Rath","year":"2016","unstructured":"Rath MM, Panigrahi MK, Pattnaik K, et al. Histological evaluation of non-alcoholic fatty liver disease and its correlation with different noninvasive scoring systems with special reference to fibrosis: a single center experience. J Clin Exp Hepatol. 2016;6:291\u20136.","journal-title":"J Clin Exp Hepatol"},{"key":"1335_CR20","first-page":"281","volume":"28","author":"P Pathik","year":"2015","unstructured":"Pathik P, Ravindra S, Ajay C, Prasad B, Jatin P, Prabha S. Fibroscan versus simple noninvasive screening tools in predicting fibrosis in high-risk nonalcoholic fatty liver disease patients from Western India. Ann Gastroenterol. 2015;28:281\u20136.","journal-title":"Ann Gastroenterol"},{"key":"1335_CR21","doi-asserted-by":"publisher","unstructured":"Parveen M, Shubha, Nisha M, Sanjay M, Vani M, et al. Non-invasive biomarkers vs liver biopsy in\u00a0diagnosing & staging NAFLD. Adv Res Gastroentero Hepatol. 2015;1:555559. https:\/\/doi.org\/10.19080\/ARGH.2015.01.555559","DOI":"10.19080\/ARGH.2015.01.555559"},{"key":"1335_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.14218\/JCTH.2020.00002","volume":"8","author":"S Khare","year":"2020","unstructured":"Khare S, Arora A, Sharma P, et al. Performance of non-invasive blood parameters for ruling out significant liver fibrosis in patients with chronic hepatitis B. J Clin Transl Hepatol. 2020;8:143\u20139.","journal-title":"J Clin Transl Hepatol"},{"key":"1335_CR23","unstructured":"Kujur KK, Garg R, Kaur S, Aggarwal S, Tapasvi C, Chawla SPS. Comparison of APRI, FIB-4 with shear wave elastography in assessment of liver fibrosis in untreated chronic hepatitis C patients. J Indian Acad Clin Med 2020;21:115\u201322."},{"key":"1335_CR24","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jceh.2016.08.001","volume":"6","author":"S Taneja","year":"2016","unstructured":"Taneja S, Tohra S, Duseja A, Dhiman RK, Chawla YK. Noninvasive assessment of liver fibrosis by transient elastography and FIB4\/APRI for prediction of treatment response in chronic hepatitis C-an experience from a tertiary care hospital. J Clin Exp Hepatol. 2016;6:282\u201390.","journal-title":"J Clin Exp Hepatol"},{"key":"1335_CR25","unstructured":"Dr. Harsh Vardhan launches Operational Guidelines for integration of Non-Alcoholic Fatty Liver Disease (NAFLD) with NPCDCS. Available at https:\/\/pib.gov.in\/pib.gov.in\/Pressreleaseshare.aspx?PRID=1699904. Accessed 30 Aug 2021."},{"key":"1335_CR26","unstructured":"Nonalcoholic fatty liver disease(NAFLD) | National Health Portal Of India. Available at https:\/\/www.nhp.gov.in\/disease\/non-communicable-disease\/nonalcoholic-fatty-liver-disease-nafld. Accessed 30 Aug 2021."}],"container-title":["Indian Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-022-01335-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12664-022-01335-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12664-022-01335-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T15:16:56Z","timestamp":1686669416000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12664-022-01335-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["1335"],"URL":"https:\/\/doi.org\/10.1007\/s12664-022-01335-3","relation":{},"ISSN":["0254-8860","0975-0711"],"issn-type":[{"value":"0254-8860","type":"print"},{"value":"0975-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"8 September 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"MP, SG, NK, and UK declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was performed conforming to the Helsinki Declaration of 1975, as revised in 2000 and 2008 concerning human and animal rights, and the authors followed the policy concerning informed consent as shown on Springer.com.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors are solely responsible for the data and the content of the paper. In no way, the Honorary Editor-in-Chief, Editorial Board Members, the Indian Society of Gastroenterology or printer\/publishers are responsible for the results\/ findings and content of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}